ClinicalTrials HQ

Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma

Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma

Recruiting · NCT07221734 · Registry updated 2026-01-21
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] MelanomaNeoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasmRecruitingPhase 32026-01-21NCT07221734

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
mAbxience Research S.L.2

19 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site 111003FunchalPortugal1
Site 117002KyivUkraine1
Site 117003TernopilUkraine1
Site 117004UzhhorodUkraine1
Site 117005Ivano-FrankivskUkraine1
Site 117006KyivUkraine1
Site 117007KyivUkraine1
Site 117010UzhhorodUkraine1
Site 117012KyivUkraine1
Site 117013KyivUkraine1
Site 117014KyivUkraine1
Site 117015ChernivtsiUkraine1
Site 117016KyivUkraine1
Site 117017KyivUkraine1
Site 117018KyivUkraine1
Site 117019UzhhorodUkraine1
Site 117020KyivUkraine1
Site 117021KyivUkraine1
Site 117022LutskUkraine1